The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• EAM S Jaishankar to Visit US from 24th to 29th December
• Elon Musk’s X Raises Premium+ Subscription Prices by 35% in India and Beyond
• Starbucks Workers Expand Strike Across Major US Cities, Including New York
• India’s GST on Popcorn Sparks Outrage
• Unimech Aerospace and Manufacturing IPO GMP Today, Lot Size & Key Finance

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.